Journal of Clinical Endocrinology & Metabolism, Vol 81, 3622-3628, Copyright © 1996 by Endocrine Society

ARTICLES

In vivo and in vitro evidence for iodide regulation of major histocompatibility complex class I and class II expression in Graves' disease

F Schuppert, S Taniguchi, S Schroder, H Dralle, A von zur Muhlen and LD Kohn
Department of Clinical Endocrinology, Hannover Medical School, Germany.

Increases in thyroid cell major histocompatibility complex (MHC) class I and class II expression have been suggested to be an important factor in the development or perpetuation of Graves' disease. It is hypothesized that elevations result in abnormal presentation of thyroid antigens to immune cells, and that iodide and/or methimazole (MMI) are effective therapeutic agents because, at least in part, of their suppression of MHC expression. In this report, we show that Graves' patients pretreated with iodide only 4 days before surgery have lower levels of MHC class I and class II RNA levels in their thyroid tissue than do patients with no iodide pretreatment (P < 0.001 and 0.03, respectively). Because patients in both groups are treated with MMI and because the change is independent of the amounts of MMI used to treat patients, the class I and class II changes cannot be ascribed to MMI. The iodide action to decrease MHC class I and class II RNA levels was duplicated using cultured human thyroid cells in vitro; the iodide effect was dependent on the iodide concentration, was not duplicated by chloride, was not associated with an alteration in cAMP levels or with a change in thyrotropin receptor RNA levels, and was evident in gamma- interferon-treated cells. The data suggest, therefore, that the therapeutic action of iodide in Graves' patients is associated with decreased MHC gene expression, that this action is a direct effect of high concentrations of iodide on the thyroid cells, and that altered MHC gene expression in the target tissue may well be associated with the development or perpetuation of Graves' disease.

This article has been cited by other articles:

				C Giuliani, M Saji, I Bucci, G Fiore, M Liberatore, D S Singer, F Monaco, L D Kohn, and G Napolitano Transcriptional regulation of major histocompatibility complex class I gene by insulin and IGF-I in FRTL-5 thyroid cells. J. Endocrinol., June 1, 2006; 189(3): 605 - 615. [Abstract] [Full Text] [PDF]

				F. Schuppert, D. Ehrenthal, A. Frilling, K. Suzuki, G. Napolitano, and L. D. Kohn Increased Major Histocompatibility Complex (MHC) Expression in Nontoxic Goiters Is Associated with Iodide Depletion, Enhanced Ability of the Follicular Thyroglobulin to Increase MHC Gene Expression, and Thyroid Autoantibodies J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 858 - 867. [Abstract] [Full Text]

				A. Kromminga, C. Hagel, R. Arndt, and F. Schuppert Serological Reactivity of Recombinant 1D Autoantigen and Its Expression in Human Thyroid and Eye Muscle Tissue: A Possible Autoantigenic Link in Graves' Patients J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2817 - 2823. [Abstract] [Full Text]

				P. L. Balducci-Silano, K. Suzuki, M. Ohta, J. Saito, M. Ohmori, V. Montani, G. Napolitano, M. Shong, S.-I. Taniguchi, M. Pietrarelli, et al. Regulation of Major Histocompatibility (MHC) Class II Human Leukocyte Antigen-DR{alpha} Gene Expression in Thyrocytes by Single Strand Binding Protein-1, a Transcription Factor That Also Regulates Thyrotropin Receptor and MHC Class I Gene Expression Endocrinology, May 1, 1998; 139(5): 2300 - 2313. [Abstract] [Full Text] [PDF]

				S.-I. Taniguchi, M. Shong, C. Giuliani, G. Napolitano, M. Saji, V. Montani, K. Suzuki, D. S. Singer, and L. D. Kohn Iodide Suppression of Major Histocompatibility Class I Gene Expression in Thyroid Cells Involves Enhancer A and the Transcription Factor NF-{kappa}B Mol. Endocrinol., January 1, 1998; 12(1): 19 - 33. [Abstract] [Full Text]

				V. Montani, M. Shong, S.-i. Taniguchi, K. Suzuki, C. Giuliani, G. Napolitano, J. Saito, M. Saji, B. Fiorentino, A. M. Reimold, et al. Regulation of Major Histocompatibility Class II Gene Expression in FRTL-5 Thyrocytes: Opposite Effects of Interferon and Methimazole Endocrinology, January 1, 1998; 139(1): 290 - 302. [Abstract] [Full Text] [PDF]

				M. Saji, M. Shong, G. Napolitano, L. A. Palmer, S.-I. Taniguchi, M. Ohmori, M. Ohta, K. Suzuki, S. L. Kirshner, C. Giuliani, et al. Regulation of Major Histocompatibility Complex Class I Gene Expression in Thyroid Cells. ROLE OF THE cAMP RESPONSE ELEMENT-LIKE SEQUENCE J. Biol. Chem., August 8, 1997; 272(32): 20096 - 20107. [Abstract] [Full Text] [PDF]